We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Mylan Sues FDA Over Exclusivity for Four Diovan Generics
Mylan Sues FDA Over Exclusivity for Four Diovan Generics
October 9, 2012
Mylan is suing the FDA over its refusal to grant 180-day exclusivity for the company’s four generic versions of Novartis’ high blood pressure drug Diovan.